FDA Clears First Bangladesh Rx Supplies From Beximco Site
This article was originally published in Scrip
Beximco Pharmaceuticals Ltd. has received US FDA approval to manufacture the antihypertensive, carvedilol, at its Tongi site in Bangladesh – the first prescription drug to be made in that country for export to the US.
You may also be interested in...
Looking to expand beyond Adcetris, Seattle Genetics pays $250m up front for Immunomedics' Phase I/II ADC for triple-negative breast cancer. Elsewhere in the ADC space, Swiss biotech Novimmune and South Korea's LegoChem are teaming up on a research collaboration.
Industry leaders including Sanofi's ex-CEO and the chiefs of Sun, Lupin, Glenmark, Dr Reddy’s and Cipla discuss how India could leapfrog its pharma R&D efforts. Could the South Korea model or a hybrid approach including bringing back top talent bolster the country’s efforts to emerge as a global innovation hot spot?
FDA officials outline the impact of using alternative tools to assess manufacturing facilities amid COVID-19 and share key experiences around these, including with remote interactive evaluations.